Table 2 Summary statistics on the proportion of positive outcomes for all sites
Outcome (BHIVA 2015 audit) | Number of sites | Number of patients | Mean (of sites) | St. dev | Min | Max |
|---|---|---|---|---|---|---|
Resistance done | 106 | 7768 | 81.0% | 12% | 42.0% | 100.0% |
Viral load measured | 106 | 6978 | 89.5% | 10% | 32.6% | 100.0% |
Adherence assessed | 106 | 6978 | 93.7% | 9% | 45.5% | 100.0% |
Medications recorded | 106 | 6978 | 89.4% | 12% | 44.7% | 100.0% |
Hep A immune | 106 | 7768 | 60.3% | 28% | 0.0% | 100.0% |
HBsAg known | 106 | 7768 | 92.5% | 16% | 0.0% | 100.0% |
Hep C tested | 106 | 7768 | 96.3% | 6% | 52.0% | 100.0% |
CVD risk assessed | 106 | 7768 | 43.6% | 28% | 0.0% | 100.0% |
Smoking assessed | 106 | 7768 | 65.9% | 26% | 0.0% | 100.0% |
Flu vaccination managed | 106 | 7768 | 55.3% | 33% | 0.0% | 100.0% |
Sexual health screening offered | 106 | 7768 | 64.8% | 23% | 6.0% | 98.1% |
Cervical cytology managed | 106 | 2663 | 74.6% | 18% | 9.1% | 100.0% |
Bone mineral density measured | 70 | 150 | 17.4% | 31% | 0.0% | 100.0% |
FRAX risk assessed | 106 | 2413 | 17.9% | 24% | 0.0% | 93.8% |
Pneumococcus vaccinated | 106 | 7411 | 25.1% | 31% | 0.0% | 100.0% |